Previous news

EMA panel backs pretomanid for drug-resistant TB

Posted on 23 Apr 2020

The Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) has recommended approval of pretomanid FGK (FGK Representative Service GmbH) for drug-resistant tuberculosis (TB).

Webinar: Hear the latest about the NiX-TB regimen for XDR-TB; Slides and Recording here!

Posted on 30 Mar 2020

On March 26, 2020, RESIST-TB hosted a webinar featuring Dr. Dan Everitt to discuss the recently published work on the NiX-TB trial, which focuses on treatment of extensively drug-resistant tuberculosis (XDR-TB). To read the publication, the article can be found below (publication #2). The presentation slides and recording have been posted here.